Dow Up0.59% Nasdaq Up0.75%

More On BLRX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials


BioLineRx, Ltd. (BLRX)

-NasdaqCM
1.60 Down 0.02(1.23%) 3:59PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue -   -   -  
Cost of Revenue -   -   -  
Gross Profit -   -   -  
Operating Expenses
Research Development12,693  17,235  11,147  
Selling General and Administrative4,992  4,624  4,192  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (17,685) (21,859) (15,339)
Income from Continuing Operations
Total Other Income/Expenses Net1,956  3,425  3,329  
Earnings Before Interest And Taxes(15,728)(18,435)(12,010)
Interest Expense1,972  2,007  1,115  
Income Before Tax(17,700)(20,442)(13,125)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(17,700)(20,442)(13,125)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (17,700) (20,442) (13,125)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (17,700) (20,442) (13,125)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.